Ataraxis
Ataraxis delivers AI-driven diagnostic tests that help clinicians choose more effective, personalized cancer treatments. The company uses foundation models and machine learning on multi-modal patient data, including digital pathology, to generate prognostic and predictive assessments; its flagship product, Ataraxis Breast, is an AI-native prognostic test clinically validated on extensive patient data. Offered as a SaaS platform for healthcare providers, Ataraxis integrates AI, digital pathology workflows, and clinical decision support for treatment selection. The technology targets oncology care pathways and aims to improve accuracy and speed compared with standard genomic assays.
Ataraxis
Ataraxis delivers AI-driven diagnostic tests that help clinicians choose more effective, personalized cancer treatments. The company uses foundation models and machine learning on multi-modal patient data, including digital pathology, to generate prognostic and predictive assessments; its flagship product, Ataraxis Breast, is an AI-native prognostic test clinically validated on extensive patient data. Offered as a SaaS platform for healthcare providers, Ataraxis integrates AI, digital pathology workflows, and clinical decision support for treatment selection. The technology targets oncology care pathways and aims to improve accuracy and speed compared with standard genomic assays.